Ketchum names new healthcare head

Share this article:
Ketchum named Ann Moravick EVP and director, global healthcare and brand advocacy.
Moravick joins the company from Publicis Consultants PR, where she was US CEO.

She is charged with spearheading the growth and expanding the global reach of the agency's healthcare practice by bridging the work of its international offices, and reports to partners Dale Bornstein, director, global practices, and Barri Rafferty, director, New York.

Before Publicis, Moravick spent 18 years at Manning, Selvage & Lee in various roles.

Bornstein said her “integrated approach to healthcare and brand advocacy will serve the evolving needs of our clients and further differentiate Ketchum's healthcare practice from others in the industry. With Ann's diverse experience, both in the US and in Europe, she will prove to be an asset to our healthcare clients as they navigate the global markets.”

Share this article:

Email Newsletters

More in News

Meaningful use not linked to quality: study

Meaningful use not linked to quality: study

A recent study of physicians found no correlation between following EHR meaningful use requirements and providing consistently higher quality of care.

Lilly Q1 sales dip

Lilly Q1 sales dip

US sales fell 34% during the quarter, largely due to lower demand and lower prices for off-patent Cymbalta and Evista.

Gilead reaps huge HCV sales, payer fury

Gilead reaps huge HCV sales, payer fury

Sovaldi's debut has been marked by plenty of criticism from payers and lawmakers, but the hep. C drug's launch, now confirmed to be the fastest of all time, has also ...